Concepedia

AD Elias

AE

14

Publications

698

Citations

11

H-Index

1990

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Yale University

University of California, San Francisco

Beth Israel Deaconess Hospital

AD Elias is an author at Dana-Farber Cancer Institute specializing in medicine, breast cancer, and oncology.

Top concepts

Publications per year

1990–2018

14

Publications

14

Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer

AD Elias, Lois Ayash, KC Anderson et al. · Blood · 1992 · 259 citations · Full text

Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering

Iain J. Webb, F Coral, J. W. Andersen et al. · Transfusion · 1996 · 76 citations

Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources.

L Chen, Michael A. Pulsipher, D Chen et al. · Journal of Clinical Investigation · 1996 · 60 citations · Full text

, , +21

High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.

Catherine Wheeler, Christiane Eickhoff, AD Elias et al. · PubMed · 1997 · 59 citations

Relationship of bcr breakpoint to chronic phase duration, survival, and blast crisis lineage in chronic myelogenous leukemia patients presenting in early chronic phase [see comments]

SW Morris, L.N. Daniel, CM Ahmed et al. · Blood · 1990 · 49 citations · Full text

Rows per page

1–5 of 14